A Phase III Clinical Trial of High-dose Rituximab (500mg/m²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCL
Clinical trial NCT06573645 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06573645
- Sponsor
- Xia Yi
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-23
- Primary completion
- 2027-01-12
- Enrollment
- 428
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.